Cabot (NYSE:CBT) CEO Sean Keohane Sells 134,895 Shares

Posted by George Bondi on Sep 1st, 2026

Cabot Corporation (NYSE:CBT – Get Free Report) CEO Sean Keohane sold 134,895 shares of the company’s stock in a transaction on Friday, August 28th. The stock was sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the completion of the transaction, the chief executive officer owned 404,134 shares of the company’s stock, valued at $34,351,390. This trade represents a 25.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Cabot Stock Down 1.1%

CBT stock opened at $82.72 on Tuesday. Cabot Corporation has a fifty-two week low of $58.33 and a fifty-two week high of $94.53. The business’s 50 day moving average price is $87.46 and its two-hundred day moving average price is $81.29. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47. The company has a market capitalization of $4.27 billion, a price-to-earnings ratio of 23.30, a price-to-earnings-growth ratio of 10.98 and a beta of 0.84.

Cabot (NYSE:CBT – Get Free Report) last announced its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, beating analysts’ consensus estimates of $1.66 by $0.01. The firm had revenue of $982.00 million for the quarter, compared to analysts’ expectations of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The company’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.90 EPS. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, analysts forecast that Cabot Corporation will post 6.35 earnings per share for the current fiscal year.

Cabot Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be paid a dividend of $0.4725 per share. The ex-dividend date of this dividend is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.3%. Cabot’s dividend payout ratio (DPR) is currently 53.24%.

Analysts Set New Price Targets

A number of research firms recently weighed in on CBT. Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a research report on Sunday, August 9th. Mizuho increased their target price on Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a research note on Thursday, June 25th. UBS Group dropped their price objective on Cabot from $97.00 to $92.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 5th. JPMorgan Chase & Co. raised their price target on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a report on Friday, August 7th. Finally, Truist Financial set a $100.00 price objective on shares of Cabot in a report on Wednesday, August 5th. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $89.00.

Check Out Our Latest Stock Report on Cabot

Hedge Funds Weigh In On Cabot

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Rothschild Investment LLC raised its position in shares of Cabot by 170.4% during the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock valued at $27,000 after purchasing an additional 259 shares during the period. Northwestern Mutual Wealth Management Co. purchased a new stake in shares of Cabot in the second quarter worth about $33,000. Global Retirement Partners LLC boosted its position in shares of Cabot by 1,606.9% during the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after acquiring an additional 466 shares during the last quarter. Geneos Wealth Management Inc. lifted its position in Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after purchasing an additional 364 shares during the last quarter. Finally, Danske Bank A S bought a new position in shares of Cabot in the 3rd quarter valued at about $38,000. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Cabot Company Profile

(Get Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.